Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.51 USD | +3.71% | +0.63% | -44.22% |
05-14 | Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression | MT |
05-14 | Neumora Therapeutics, Inc. Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression | CI |